DRX HBA1C - FOR PRESCRIPTION HOME USE— 510(k) K000885

Substantially Equivalent

Metrika, Inc.

FDA 510(k) clearance K000885 for DRX HBA1C - FOR PRESCRIPTION HOME USE, Substantially Equivalent on 2000-09-26. Applicant: Metrika, Inc..

Clearance details

Applicant: Metrika, Inc.
Product code: Code LCP
Advisory panel: Hematology
Date received: 2000-03-20
Decision date: 2000-09-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Sunnyvale, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.